Sign in Register

All drugs.

Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.

Filters

Filter

Enter at least 3 characters to search the full directory.

Showing 26–41 of 41 drugs · filtered

Sort

GEFITINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR EXON 21 L858R SUBSTITUTION MUTATION ·+1

INGENUS PHARMAC

LAZCLUZE (lazertinib mesylate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH EGFR EXON 19 DELETION ·+1

JANSSEN BIOTECH, Inc.

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

AREVA PHARMACEU

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

ALEMBIC PHARMAC

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

SUN PHARMACEUTI

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

ZYDUS PHARMACEU

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

NOVADOZ PHARMAC

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

ARMAS PHARMACEU

ERLOTINIB HCL

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ADENOCARCINOMA OF PANCREAS ·+2

TEVA USA

GEFITINIB

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · METASTATIC NON-SMALL CELL LUNG CANCER WITH EGFR EXON 21 L858R SUBSTITUTION MUTATION ·+1

NATCO PHARMA US

ENSACOVE (ensartinib hydrochloride)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER

XCOVERY HOLDING

IBTROZI (taletrectinib adipate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ROS1 POSITIVE NON-SMALL CELL LUNG CANCER

NUVATION BIO IN

TABRECTA (capmatinib hydrochloride)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH MESENCHYMAL-EPITHELIAL TRANSITION (MET) EXON 14 SKIPPING

Novartis Pharmaceuticals

ZYKADIA (ceritinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · ANAPLASTIC LYMPHOMA KINASE POSITIVE NON-SMALL CELL LUNG CANCER

Novartis Pharmaceuticals

AFATINIB (afatinib dimaleate)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · EPIDERMAL GROWTH FACTOR RECEPTOR POSITIVE NON-SMALL CELL LUNG CANCER ·+1

CAMBER PHARMACE

ZEGFROVY (sunvozertinib)

ANTINEOPLASTIC - PROTEIN-TYROSINE KINASE INHIBITORS · NON-SMALL CELL LUNG CANCER WITH EGFR EXON 20 INSERTION MUTATION

DIZAL/ASTRAZENE